UBS Sees Continued Upside in Amgen (AMGN), Lifts Target to $400

UBS Sees Continued Upside in Amgen (AMGN), Lifts Target to $400

Original Source

Read the full article at Finance →

KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.